PCG three-lens brief
Evidence-based stock research on PCG. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 15.3pp over 30 days. · Negative free cash flow last quarterly (-$5.57B).
- Underperforming SPY by 15.3pp over 30 days.
- Analyst mean target $22.84 — 38% above current (16 analysts).
- Negative free cash flow last quarterly (-$5.57B).
- Debt-to-equity of 187.9 — balance-sheet-heavy.
PCG closed at $16.61 (-1.31%) as of 2026-04-25. Market cap: $36.58B. P/E (trailing) 12.9. Positives: analyst mean target $22.84 — 38% above current (16 analysts).. Concerns: underperforming SPY by 15.3pp over 30 days.; negative free cash flow last quarterly (-$5.57B).. Last quarter: Revenue $6.88B, net income $858.00M, free cash flow -$5.57B.
Why three lenses on PCG, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PCGacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PCG" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PCG brief"></iframe>